Anavex Life Sciences Corp.
AVXL· Nasdaq
AVXLAnavex Life Sciences Corp.
Filed Aug 7, 2017 · 10-Q · 38 days after period end · 0001615774-17-004118
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Net Income | -$3.61M | -$2.24M | -$4.24M | -$1.01M |
| EPS Diluted | -$0.04 | -$0.06 | -$0.22 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR
ended Jun 30, 2017 · filed Aug 7, 2017 · 38 d after period end
